ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Lyell Immunopharma Inc

Lyell Immunopharma Inc (LYEL)

1.38
0.00
(0.00%)
Closed 29 June 6:00AM
1.45
0.00
( 0.00% )
Pre Market: 6:00PM
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Return on Assets (%) -46.569-27.935-24.583-17.736-27.807
Return on Equity (%) 232.885101.315-78.53-20.773-31.532
Return on Invested Capital (%) -60.697-47.725-37.448-28.59-37.563
Operating Margin (%) -19692.085-2636.307-2349.474-216.239-180486.154
Net Profit Margin (%) -19692.085-2636.307-2349.474-216.239-180486.154
Book Value Per Share 36.49546.1433.833.3392.6
Earnings Per Share -11.571-13.132-1.031-0.734-0.932
Cash Per Share 8.6469.0181.210.4950.578
Working Capital Per Share 37.40436.4972.3882.4612.065
Operating Profit Per Share 0.0591.1040.0530.3580.012
EBIT Per Share -11.571-13.132-1.031-0.734-0.932
EBITDA Per Share -11.571-13.132-1.031-0.734-0.932
Free Cash Flow Per Share -10.248-10.102-0.817-0.709-1.001

Liquidity Ratios

Year End 31 December 2023 20192020202120222023
Current Ratio 19.97112.5313.417.58916.069
Quick Ratio 19.7812.4313.15417.28815.824
Inventory Turnover (Days) N/A N/A N/A N/A N/A
Shares Outstanding 11.18M15.57M242.74M249.57MN/A

Key Stats and Ratios

Year End 31 December 2023 Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Shares Outstanding 247.11M249.24M249.57MN/AN/AN/AN/AN/A
Return on Assets (%) N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity (%) N/A N/A N/A N/A N/A N/A N/A N/A
Return on Invested Capital (%) N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin (%) N/A N/A N/A -103013.846 N/A N/A N/A -2022233.333
Net Profit Margin (%) N/A N/A N/A -103013.846 N/A N/A N/A -2022233.333
Sales Per Share N/A N/A N/A N/A N/A N/A N/A N/A
Book Value Per Share N/A N/A N/A N/A N/A N/A N/A N/A
Earnings Per Share N/A N/A N/A N/A N/A N/A N/A N/A
Cash Per Share N/A N/A N/A N/A N/A N/A N/A N/A
Working Capital Per Share N/A N/A N/A N/A N/A N/A N/A N/A
Operating Profit Per Share N/A N/A N/A N/A N/A N/A N/A N/A
EBIT Per Share N/A N/A N/A N/A N/A N/A N/A N/A
EBITDA Per Share N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow Per Share N/A N/A N/A N/A N/A N/A N/A N/A
Current Ratio N/A N/A N/A 20.275 N/A N/A N/A 16.511
Quick Ratio N/A N/A N/A 19.897 N/A N/A N/A 16.267
Inventory Turnover (Days) N/A N/A N/A N/A N/A N/A N/A N/A

Key Stats and Ratios

Market Cap 369.66M
Price to Earnings Ratio -1.58
Price to Sales Ratio 126.09
Price to Cash Ratio 2.54
Price to Book Ratio 0.56
Dividend Yield -

Share Statistics

Shares Outstanding 254.94M
Average Volume (1 week) 3.9M
Average Volume (1 Month) 1.62M
52 Week Change -53.97%
52 Week High 3.41
52 Week Low 1.18
More Ratios Coming Soon!